Tarsus Pharmaceuticals Stock Earns Upgrade To RS Rating
On Thursday, Tarsus Pharmaceuticals stock got an upgrade to its Relative Strength (RS) Rating, from 76 to 82.

Source: Investor's Business Daily
On Thursday, Tarsus Pharmaceuticals stock got an upgrade to its Relative Strength (RS) Rating, from 76 to 82.